Cargando…

Role of gadolinium enhanced cardiac magnetic resonance in recent onset non-ischemic cardiomyopathy: a systematic review and metanalysis

Detalles Bibliográficos
Autores principales:	Eifer, Diego A, Torres, Felipe S, Foppa, Murilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328562/ http://dx.doi.org/10.1186/1532-429X-17-S1-P173

Ejemplares similares

Late gadolinium enhancement by cardiac magnetic resonance imaging predicts reverse remodeling in patients with non-ischemic cardiomyopathy receiving β blocker therapy
por: Kida, Keisuke, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

Late gadolinium-enhancement cardiovascular magnetic resonance imaging and angiographic characteristics of patients referred for evaluation of new onset cardiomyopathy
por: Danilov, Tatyana, et al.
Publicado: (2011)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
por: van Hoorn, Frans, et al.
Publicado: (2012)

Cardiac magnetic resonance left ventricular quantitative analysis post gadolinium: reliable and reproducible?
por: Rofe, Christopher J, et al.
Publicado: (2011)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Late Gadolinium Enhancement does occur in the Tako-Tsubo Cardiomyopathy - a quantitative cardiovascular magnetic resonance study
por: Hamilton-Craig, Christian, et al.
Publicado: (2011)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging
por: Holmström, Miia, et al.
Publicado: (2011)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

Epicardial adipose tissue evaluated with cardiac magnetic resonance in normal subject and in patients with ischemic and dilated cardiomyopathies
por: Secchi, Francesco, et al.
Publicado: (2016)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Cardiac magnetic resonance evidence of diffuse myocardial fibrosis in patients with mitral valve prolapse
por: Bui, An H, et al.
Publicado: (2015)

Preclinical evidence of remote ischemic conditioning in ischemic stroke, a metanalysis update
por: Torres-Querol, Coral, et al.
Publicado: (2021)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

Dual contrast enhanced cardiac MRI using manganese and gadolinium in patients with severe ischemic cardiomyopathy detects the peri-infarct region (PIR)
por: Matsuura, Yuka, et al.
Publicado: (2014)

Prognostic impact of late gadolinium enhancement cardiac magnetic resonance in the risk stratification of heart transplant patients
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Early markers of heart damage in systemic sclerosis: role of cardiac magnetic resonance with late gadolinium enhancement
por: Lario, Chiara Valentina, et al.
Publicado: (2016)

Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility
por: Watanabe, Eri, et al.
Publicado: (2009)

Subcutaneous fat thickness, but not epicardial fat thickness, parallel weight reduction after bariatric surgery: a cardiac magnetic resonance study
por: Foppa, Murilo, et al.
Publicado: (2013)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance
por: Igual, Begoña M, et al.
Publicado: (2011)

The use of cardiac magnetic resonance imaging in diagnosing and characterizing hypertrophic cardiomyopathy
por: Ogele, Emmanuel, et al.
Publicado: (2016)

Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events
por: Coelho-Filho, Otavio, et al.
Publicado: (2011)

Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease
por: Dweck, Marc R., et al.
Publicado: (2016)

Cardiac magnetic resonance imaging and gadolinium angiography for neonates and small infants: a 10-year single institutional experience
por: Rangamani, Sheela, et al.
Publicado: (2012)

Prognostic utility of late gadolinium enhancement cardiac magnetic resonance imaging in coronary artery disease: a meta-analysis
por: Chan, Raymond H, et al.
Publicado: (2013)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Cardiac magnetic resonance imaging and computed tomography in ischemic cardiomyopathy: an update
por: Assunção, Fernanda Boldrini, et al.
Publicado: (2016)

Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions
por: Scatteia, Alessandra, et al.
Publicado: (2023)

Delayed-enhanced magnetic resonance imaging for identifying the ventricular arrhythmia substrate in non-ischemic cardiomyopathy
por: Desjardins, Benoit, et al.
Publicado: (2009)

Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization
por: Kwon, Deborah H., et al.
Publicado: (2018)

Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
por: Nacif, Marcelo, et al.
Publicado: (2012)

Cardiovascular magnetic resonance with late gadolinium enhancement improves mortality prediction beyond echocardiography: a comparative effectiveness study
por: Schelbert, Erik B, et al.
Publicado: (2012)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
por: Lander, Bradley S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0om8tri0t39t0c6tb804ard4o